Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes
2018-003121-29Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in arterial calcification, arteriosclerosis obliterans and diabetes mellitus type 1 (T1D) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Change in below-knee arterial calcification score. Started Dec 2019; status: active.
02
Drugs
metformin
03
Conditions
arterial calcificationarteriosclerosis obliteransdiabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2018-003121-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003121-29.